Welcome to Microbion
Microbion is a pioneer in developing innovative, environmentally responsible products that address the issue of biofilm control, both in health and in industry. Products currently in development include antimicrobial drugs that can overcome “superbugs” such as MRSA and carbapenem resistant Gram-negative bacteria, as well as products to protect surgically implanted medical devices from microbial contamination.
Jared Carney, Former Milken Institute CSO, Joins Microbion’s Board of Directors0 commentsAs the CEO of Lightdale, Carney Brings Leadership and Experience to Support Microbion’s Growth Strategy...
Microbion, U Penn and UCSF awarded $2.5M grant from the U.S. Department of Defense0 commentsBozeman, MT – Oct. 30, 2012 – Microbion Corporation announced the award of a $2.5...
Initiation of Phase 1 Clinical Trial for Topical treatment of Acute Skin and Skin Structure Infections0 commentsMicrobion Corporation, a Montana-based pharmaceutical company focused on development of novel therapeutics for treatment of...